STOCK TITAN

ImmuCell CEO exercises options for 16,393 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

ImmuCell Corp. (ICCC) President and CEO Paul Francis Olivier te Boekhorst exercised options on November 12, 2026, to acquire 16,393 common shares at $6.10 per share. Afterward, his reported direct common-stock position was 34,131 shares, and 57,884 shares remained subject to the option, which expires November 7, 2035. A correction note states that the beneficial-ownership total corrects the June 22, 2026 Form 4: the share-purchase count was correct, but total ownership was overstated by 47 shares.

Insider te Boekhorst Paul Francis Olivier
Role President and CEO
Type Security Shares Price Value
Exercise Incentive Stock Options (Right to buy) F2, F3 16,393 $0.00 $0.00
Exercise Common Stock, par value $.10 per share F1 16,393 $6.10 $100K
Holdings After Transaction: Incentive Stock Options (Right to buy) — 57,884 options (Direct); Common Stock, par value $.10 per share — 34,131 shares (Direct)
Footnotes (3)
  1. F1. Total beneficial ownership shown here reflects a correction in the amount previously reported June 22, 2026 on Form 4 (which correctly reported the number of shares purchases but overstated total ownership by 47 shares).
  2. F2. The stock option vests in three annual installments of 24.759 shares on the first, second and third anniversaries of the November 7, 2026 grant date. The first installment vested on November7, 2026.
  3. F3. Represents the number of shares remaining subject to the option following the reported exercise.
Common shares acquired through option exercise 16,393 shares November 12, 2026
Exercise price $6.10 per share Option exercise on November 12, 2026
Direct common shares after transaction 34,131 shares Reported following the November 12, 2026 transaction
Shares remaining subject to option 57,884 shares Following the reported exercise
Option expiration November 7, 2035 Reported expiration date
Incentive Stock Options technical
"Incentive Stock Options (Right to buy)"
Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.
vests technical
"stock option vests in three annual installments"
beneficial ownership financial
"Total beneficial ownership shown here reflects a correction"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ICCC shares did President and CEO Paul Francis Olivier te Boekhorst acquire through the option exercise?

He acquired 16,393 common shares at $6.10 per share on November 12, 2026, through an option exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
te Boekhorst Paul Francis Olivier

(Last)(First)(Middle)
C/O IMMUCELL CORPORATION
56 EVERGREEN DRIVE

(Street)
PORTLAND MAINE 04103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IMMUCELL CORP /DE/ [ ICCC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $.10 per share11/12/2026M16,393A$6.134,131(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Stock Options (Right to buy)$6.111/12/2026M16,393 (2)11/07/2035Common Stock16,393$057,884(3)D
Explanation of Responses:
1. Total beneficial ownership shown here reflects a correction in the amount previously reported June 22, 2026 on Form 4 (which correctly reported the number of shares purchases but overstated total ownership by 47 shares).
2. The stock option vests in three annual installments of 24.759 shares on the first, second and third anniversaries of the November 7, 2026 grant date. The first installment vested on November7, 2026.
3. Represents the number of shares remaining subject to the option following the reported exercise.
/s/ Timothy C. Fiori Attorney-in-Fact11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading